Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-02 Sale | 2026-07-06 4:51 pm | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 2,161 | $13.64 | $29,476 | 277,821 (Direct) | View |
| 2026-06-29 Sale | 2026-07-01 8:08 pm | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 56,333 | $12.23 | $688,756 | 279,982 (Direct) | View |
| 2026-05-11 Sale | 2026-05-13 5:18 pm | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 15,309 | $11.02 | $168,705 | 232,617 (Direct) | View |
| 2026-03-10 Sale | 2026-03-12 6:17 pm | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 5,124 | $10.35 | $53,033 | 247,926 (Direct) | View |
| 2025-10-09 Sale | 2025-10-10 6:38 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 20,811 | $12.62 | $262,635 | 216,162 (Direct) | View |
| 2025-09-29 Sale | 2025-10-01 5:02 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 7,624 | $10.03 | $76,469 | 236,973 (Direct) | View |
| 2025-09-10 Sale | 2025-09-12 4:30 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 7,734 | $10.02 | $77,495 | 244,597 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-31 Option Award | 2026-07-06 4:51 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 951 | $6.9955 | 338,053 (Direct) | View |
| 2026-06-30 Option Award | 2026-07-06 4:51 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 1,453 | $10.18 | 338,053 (Direct) | View |
| 2026-07-01 Tax Withholding | 2026-07-06 4:51 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 6,818 | $13.09 | 338,053 (Direct) | View |
| 2026-07-02 Exercise | 2026-07-06 4:51 pm | N/A 2035-01-02 | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 2,161 | $0 | 277,821 (Direct) | View |
| 2026-07-02 Exercise | 2026-07-06 4:51 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 2,161 | $7.86 | 277,821 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-01 8:08 pm | N/A 2035-01-02 | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 36,725 | $0 | 279,982 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-01 8:08 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 36,725 | $7.86 | 279,982 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:21 pm | 2027-05-29 2036-05-29 | REGENXBIO Inc. | RGNX | Tasse Daniel Director | 56,407 | $0 | 75,461 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:20 pm | 2027-05-29 2036-05-29 | REGENXBIO Inc. | RGNX | STUMP DAVID C Director | 56,407 | $0 | 75,461 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:20 pm | 2027-05-29 2036-05-29 | REGENXBIO Inc. | RGNX | Zachary Jennifer Director | 56,407 | $0 | 78,471 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:16 pm | 2027-05-29 2036-05-29 | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 56,407 | $0 | 542,525 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:16 pm | 2027-05-29 2036-05-29 | REGENXBIO Inc. | RGNX | MIGAUSKY GEORGE V Director | 56,407 | $0 | 75,461 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:16 pm | 2027-05-29 2036-05-29 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 56,407 | $0 | 75,461 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:16 pm | 2027-05-29 2036-05-29 | REGENXBIO Inc. | RGNX | Glucksmann Alexandra Director | 56,407 | $0 | 75,461 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:15 pm | 2027-05-29 2036-05-29 | REGENXBIO Inc. | RGNX | Fox Allan M. Director | 56,407 | $0 | 2,957,927 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-02 5:15 pm | 2027-05-29 2036-05-29 | REGENXBIO Inc. | RGNX | Bennett Jean Director | 56,407 | $0 | 75,461 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 4:47 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Strategy & Legal Officer | 4,700 | $11.16 | 210,667 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 4:46 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 5,267 | $11.16 | 253,050 (Direct) | View |
| 2026-01-27 Exercise | 2026-01-29 4:58 pm | N/A 2026-01-28 | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 225,000 | $0 | 711,118 (Direct) | View |
| 2026-01-27 Exercise | 2026-01-29 4:58 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 225,000 | $13.09 | 711,118 (Direct) | View |
| 2026-01-27 Tax Withholding | 2026-01-29 4:58 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 221,753 | $13.41 | 711,118 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 4:44 pm | N/A 2036-01-06 | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 101,249 | $0 | 293,719 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 4:43 pm | N/A 2036-01-06 | REGENXBIO Inc. | RGNX | Malzahn Craig Chief Technology Officer | 101,249 | $0 | 117,596 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 4:43 pm | N/A 2036-01-06 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 378,515 | $0 | 576,118 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 4:39 pm | N/A 2036-01-06 | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Strategy & Legal Officer | 113,399 | $0 | 255,017 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 4:33 pm | N/A 2036-01-06 | REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer | 113,399 | $0 | 167,367 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-06 4:32 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 18,559 | $14.4 | 197,603 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-06 4:31 pm | N/A N/A | REGENXBIO Inc. | RGNX | Malzahn Craig Chief Technology Officer | 1,238 | $14.4 | 16,347 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-06 4:31 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Strategy & Legal Officer | 9,793 | $14.4 | 141,618 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-06 4:31 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 18,247 | $14.4 | 192,470 (Direct) | View |
| 2025-09-01 Tax Withholding | 2025-09-03 4:49 pm | N/A N/A | REGENXBIO Inc. | RGNX | Malzahn Craig Chief Technology Officer | 234 | $8.93 | 17,585 (Direct) | View |
| 2025-09-01 Tax Withholding | 2025-09-03 4:47 pm | N/A N/A | REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer | 4,901 | $8.93 | 53,968 (Direct) | View |
| 2025-08-01 Tax Withholding | 2025-08-04 5:17 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Strategy & Legal Officer | 4,699 | $8.19 | 151,411 (Direct) | View |
| 2025-07-01 Tax Withholding | 2025-07-03 6:53 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 4,701 | $8.23 | 252,331 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:37 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Fox Allan M. Director | 47,583 | $0 | 2,941,335 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:33 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Zachary Jennifer Director | 47,583 | $0 | 61,879 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:33 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Tasse Daniel Director | 47,583 | $0 | 58,869 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:33 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | STUMP DAVID C Director | 47,583 | $0 | 58,869 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:32 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 47,583 | $0 | 522,686 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:32 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | MIGAUSKY GEORGE V Director | 47,583 | $0 | 58,869 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:32 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Glucksmann Alexandra Director | 47,583 | $0 | 58,869 (Direct) | View |